Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1321Question →

A 62-year-old woman is brought to the emergency department after her family noticed sudden-onset difficulty speaking and right-sided facial droop that began 45 minutes ago. Her medical history includes hypertension and type 2 diabetes mellitus. She is not taking any anticoagulant medications. Vital signs show a blood pressure of 165/90 mm Hg, heart rate of 82/min, and respiratory rate of 16/min. Neurological examination reveals expressive aphasia, right-sided facial droop, and right upper extremity weakness. The physician prepares to evaluate the patient for intravenous thrombolysis. Which of the following diagnostic tests MUST be obtained and reviewed prior to the administration of intravenous alteplase? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Non-contrast computed tomography of the head; Point-of-care blood glucose measurement

Answer

The only tests required prior to administering intravenous alteplase are a non-contrast computed tomography of the head and a point-of-care blood glucose measurement.
The administration of intravenous alteplase (tPA) for acute ischemic stroke is highly time-sensitive. According to current American Heart Association/American Stroke Association (AHA/ASA) guidelines, the only two diagnostic tests that are strictly required prior to initiating tPA in a standard patient are a non-contrast CT scan of the head (to rapidly rule out intracranial hemorrhage, an absolute contraindication) and a point-of-care blood glucose measurement (to rule out hypoglycemia, a common stroke mimic).

Step-by-Step Solution

1
Identify the patient's clinical presentation and suspected diagnosis.
The patient is presenting within the 4.5-hour therapeutic window with signs of an acute ischemic stroke.
Determining the time of symptom onset and clinical presentation is necessary to evaluate candidacy for intravenous thrombolysis.
2
Determine the mandatory diagnostic prerequisites for intravenous thrombolysis.
Guidelines mandate ruling out intracranial hemorrhage and hypoglycemia.
Alteplase is contraindicated in hemorrhagic stroke, and hypoglycemia can perfectly mimic stroke symptoms (stroke mimic) but requires completely different treatment.
3
Select the specific tests that fulfill these prerequisites without unnecessarily delaying treatment.
Non-contrast CT of the head and point-of-care blood glucose measurement are selected.
Other tests, while useful for overall management, should not delay the time-sensitive administration of alteplase in a patient without specific risk factors (e.g., current anticoagulant use).

Key Concept

In patients with suspected acute ischemic stroke who are candidates for thrombolytic therapy, only a non-contrast head CT (to rule out hemorrhage) and a blood glucose assessment (to rule out hypoglycemia) are strictly required before initiating intravenous alteplase.
Question 1322Question →

During a scheduled ambulatory clinic visit, a 5757-year-old woman reports a 33-day history of escalating pain and swelling in her left lower extremity. Her medical history is significant for hypertension, diabetic nephropathy, and morbid obesity. Her current medications include nifedipine, sitagliptin, and subcutaneous insulin detemir. Blood pressure is 142/88142/88 mmHg, pulse is 8282/min, and respirations are 1616/min. Pulse oximetry shows 98%98\% on room air. Physical examination reveals that the left calf is erythematous, warm, and measures 55 cm larger in circumference than the right calf. A compressive duplex ultrasonography reveals an acute, noncompressible thrombus in the left popliteal vein. Laboratory studies show:

Hemoglobin: 11.811.8 g/dL
Platelet count: 230,000230,000/mm 3^3
Serum creatinine: 3.13.1 mg/dL
Estimated glomerular filtration rate (eGFR): 1919 mL/min/1.731.73 m 2^2

The patient is hemodynamically stable with normal oxygenation. The physician determines she is an appropriate candidate for immediate outpatient management of her deep vein thrombosis.

Which of the following is the most appropriate pharmacologic intervention for this patient?

Show answer & explanation

Answer: Oral apixaban

Answer

Oral apixaban is the correct choice because it is safe and approved for use in severe renal impairment and allows for outpatient treatment without routine monitoring.
Oral apixaban is the most appropriate pharmacologic intervention for this patient. She requires immediate anticoagulation for an acute deep vein thrombosis in an outpatient setting. However, her severe chronic kidney disease (eGFR 1919 mL/min/1.731.73 m 2^2) limits her therapeutic options. Apixaban is primarily metabolized by the liver and is FDA-approved and considered safe for patients with severe renal impairment (including end-stage renal disease on dialysis). It provides effective anticoagulation without the need for parenteral bridging or routine coagulation monitoring.

Step-by-Step Solution

1
Diagnose the acute condition and determine the appropriate treatment setting.
The patient has an acute left lower extremity deep vein thrombosis. Being hemodynamically stable, she is a candidate for outpatient anticoagulation.
Initial stabilization and triage guide the choice of inpatient versus outpatient pharmacologic regimens.
2
Evaluate patient-specific contraindications to standard therapies.
The patient has severe chronic kidney disease with an eGFR of 1919 mL/min/1.731.73 m 2^2.
Renal function strictly dictates the safety, dosing, and selection of various anticoagulant medications.
3
Select the optimal anticoagulant based on the renal profile and outpatient setting.
Oral apixaban is selected.
Apixaban undergoes minimal renal clearance compared to other direct oral anticoagulants and is safe in severe renal impairment (eGFR <25< 25 mL/min/1.731.73 m 2^2). It requires no injection bridging or laboratory monitoring.

Key Concept

Safe selection of oral anticoagulants in the setting of acute deep vein thrombosis and severe chronic kidney disease.
Question 1323Question →

A 55-year-old man develops abrupt right-sided chest pain and dyspnea while recovering on the surgical ward. He underwent a partial colectomy for perforated diverticulitis 77 days ago. His postoperative recovery was complicated by severe sepsis and ischemic acute tubular necrosis, for which he currently requires hemodialysis every other day. Since the day of surgery, he has been receiving twice-daily subcutaneous injections of unfractionated heparin for deep vein thrombosis prophylaxis.

Current vital signs include a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 110/70 mm Hg110/70\text{ mm Hg}, heart rate of 118/min118/\text{min}, and respiratory rate of 24/min24/\text{min}. Pulse oximetry shows 92%92\% on 4 L/min4\text{ L/min} supplemental oxygen via nasal cannula.

A CT pulmonary angiogram confirms an acute segmental pulmonary embolism in the right lower lobe.

Today's laboratory results show:
Hemoglobin: 9.8 g/dL9.8\text{ g/dL}
Platelet count: 48,000/mm348,000/\text{mm}^3 (down from 260,000/mm3260,000/\text{mm}^3 on admission)
Blood urea nitrogen: 52 mg/dL52\text{ mg/dL}
Serum creatinine: 5.1 mg/dL5.1\text{ mg/dL}

The surgical team suspects heparin-induced thrombocytopenia (HIT). In addition to immediately discontinuing all heparin products, which of the following is the most appropriate pharmacologic intervention?

Show answer & explanation

Answer: Initiate intravenous argatroban

Answer

The most appropriate pharmacologic intervention is to initiate intravenous argatroban, as it provides necessary non-heparin anticoagulation and is safe to use in patients with severe renal impairment.
The correct answer is to initiate intravenous argatroban. This patient has developed a new pulmonary embolism and a significant drop in platelet count (greater than 50%) exactly 7 days after starting unfractionated heparin. This clinical picture is highly suspicious for heparin-induced thrombocytopenia (HIT) complicated by active thrombosis. The immediate management of HIT requires the cessation of all heparin-containing products and the rapid initiation of an alternative, non-heparin systemic anticoagulant to manage the hypercoagulable state. Because this patient has severe acute kidney injury requiring hemodialysis, the preferred agent is argatroban. Argatroban is a direct thrombin inhibitor that is hepatically metabolized, making it safe to use in patients with severe renal impairment without the need for significant dose adjustments.

Step-by-Step Solution

1
Recognize the clinical presentation of heparin-induced thrombocytopenia (HIT).
The patient has a new pulmonary embolism and a platelet count drop of greater than 50% occurring 7 days after unfractionated heparin exposure, yielding a high 4T score for HIT.
Accurate diagnosis is required to guide the critical decision to stop all current heparin therapy.
2
Determine the immediate management goals for HIT complicated by thrombosis (HITT).
All heparin-containing products must be stopped, and a non-heparin systemic anticoagulant must be initiated immediately.
Despite profound thrombocytopenia, HIT is a severely prothrombotic state, and the new pulmonary embolism requires acute treatment.
3
Evaluate the patient's comorbidities to select the safest non-heparin anticoagulant.
The patient has severe acute kidney injury requiring hemodialysis. Argatroban is hepatically metabolized, whereas alternatives like fondaparinux are renally cleared.
Choosing a renally cleared drug in this patient would lead to toxic accumulation and severe bleeding.
4
Select the final optimal pharmacologic intervention.
Intravenous argatroban is chosen.
It fulfills the requirement for a non-heparin anticoagulant while remaining pharmacokinetically safe in the setting of end-stage renal disease or severe acute kidney injury.

Key Concept

In suspected heparin-induced thrombocytopenia (HIT), all heparin must be discontinued and a non-heparin anticoagulant started. Argatroban, a direct thrombin inhibitor, undergoes hepatic metabolism and is the preferred agent for patients with concurrent severe renal impairment.
Question 1324Question →

Emergency medical services arrive with an elderly female patient, aged 7474 years, complaining of an abrupt onset of excruciating left lower extremity pain that started 44 hours prior to arrival. Her medical history is significant for hypertension, type 22 diabetes mellitus, and paroxysmal atrial fibrillation. She admits she stopped taking her prescribed apixaban two weeks ago due to financial difficulties.

On physical examination, the patient is in obvious distress. Her temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), heart rate is 118/min118/\text{min} and irregular, blood pressure is 145/88 mmHg145/88\text{ mmHg}, and respiratory rate is 18/min18/\text{min}. Evaluation of the left lower extremity reveals it is pale, cold to the touch, and exhibits mottled skin distal to the knee. The patient reports profound numbness over the dorsum of the foot and is completely unable to dorsiflex her toes. Palpation of the left femoral pulse is normal, but the popliteal, dorsalis pedis, and posterior tibial pulses are absent. Bedside continuous-wave Doppler evaluation demonstrates absent arterial signals over the distal left leg, while venous signals remain audible.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous heparin administration and emergent open surgical embolectomy

Answer

The correct answer is the administration of intravenous heparin followed by emergent open surgical embolectomy.
The patient has acute limb ischemia (ALI), classified as Rutherford Category IIb (immediately threatened). This is evidenced by sensory loss, a motor deficit (inability to dorsiflex), and the absence of arterial Doppler signals with preserved venous flow. In a patient with atrial fibrillation, this presentation is highly suspicious for an arterial embolus. The definitive management for Rutherford IIb ALI is immediate systemic anticoagulation (intravenous heparin) followed by emergent surgical revascularization, typically via open surgical embolectomy, to rapidly restore perfusion before irreversible neuromuscular damage occurs.

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's presentation.
The patient has Acute Limb Ischemia (ALI), presenting with the classic signs: pain, pallor, pulselessness, paresthesia, and paralysis (the '5 Ps').
Recognizing the syndrome dictates the urgency of the condition and frames the severity assessment.
2
Classify the severity of the ischemia using the Rutherford criteria based on physical exam findings.
The presence of rest pain, sensory loss beyond the toes, and a motor deficit (inability to dorsiflex), combined with inaudible arterial but audible venous Doppler signals, places this in Category IIb (immediately threatened).
The Rutherford category directly dictates the procedural intervention required. Category IIb specifically delineates a short window for limb salvage.
3
Determine the likely etiology of the ischemia.
The abrupt onset of symptoms in an elderly patient with noncompliant atrial fibrillation strongly points to an arterial thromboembolism.
Embolic occlusions in otherwise healthy vessels are highly amenable to rapid mechanical extraction.
4
Select the appropriate surgical/procedural intervention.
Category IIb ALI requires immediate revascularization. Open surgical embolectomy (e.g., using a Fogarty catheter) is the fastest and most appropriate definitive management.
Alternative therapies like catheter-directed thrombolysis act too slowly, and delaying for advanced imaging (CTA) increases the risk of irreversible necrosis.

Key Concept

Management of Acute Limb Ischemia (Rutherford Category IIb)
Question 1325Question →

A retired construction worker, 68 years of age, is evaluated in the critical care resuscitation bay shortly after experiencing a sudden, excruciating pain between his shoulder blades that he describes as "ripping." He has a history of poorly controlled hypertension and tobacco use. Vital signs reveal a heart rate of 122/min, a respiratory rate of 22/min, and a blood pressure of 78/40 mm Hg in the right arm. On physical examination, the patient is visibly diaphoretic, pale, and lethargic. Cardiopulmonary auscultation reveals a new, faint early decrescendo diastolic murmur at the right upper sternal border. The lungs are clear to auscultation bilaterally. Electrocardiography demonstrates sinus tachycardia with non-specific ST-segment changes. Intravenous fluid resuscitation is immediately initiated via two large-bore peripheral catheters. Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Transesophageal echocardiography

Answer

Transesophageal echocardiography
This patient's presentation of sudden-onset, 'ripping' back pain combined with a new diastolic decrescendo murmur (indicating acute aortic regurgitation) is highly suspicious for an acute ascending aortic dissection (Stanford type A). The patient is in hemodynamic shock, which in this context can result from aortic rupture, cardiac tamponade, or acute severe aortic valve incompetence. When selecting the next step in the diagnostic workup for a suspected aortic dissection, the patient's hemodynamic stability is the most critical deciding factor. For hemodynamically unstable patients, transesophageal echocardiography is the most appropriate next step. It provides excellent visualization of the ascending aorta and aortic valve, boasts high sensitivity and specificity, and crucially, can be performed rapidly at the bedside or in the operating room. This prevents the dangerous transport of an unstable patient away from the resuscitation area.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the presentation.
Sudden, tearing back pain with a new decrescendo diastolic murmur (aortic regurgitation) strongly suggests an acute ascending aortic dissection.
Recognizing the classic triad of tearing pain, pulse/blood pressure differentials, and widening mediastinum or new murmur narrows the differential diagnosis.
2
Assess the patient's hemodynamic stability.
The patient is hypotensive, tachycardic, diaphoretic, and lethargic, indicating hemodynamic instability and shock.
Hemodynamic status dictates whether the patient can be safely transported for imaging or if bedside imaging is mandatory.
3
Select the appropriate diagnostic imaging modality.
Transesophageal echocardiography is chosen.
It offers high sensitivity and specificity for aortic dissection and can be performed at the bedside in the emergency department or operating room, maintaining patient safety.

Key Concept

In hemodynamically unstable patients with suspected acute aortic dissection, bedside transesophageal echocardiography (TEE) is the diagnostic imaging modality of choice to avoid the risks of transporting an unstable patient to the radiology suite.

Alternative Method

In some specialized trauma centers with 'hybrid' operating rooms, the patient might be taken directly to the OR where both resuscitation and advanced imaging (like intraoperative TEE or portable CT) can occur simultaneously.
Estimated Time:1m 30s
Question 1326Question →

Match each of the following ambulatory patient profiles with the single most appropriate guideline-concordant preventive care intervention. Each patient is asymptomatic, has no acute complaints, and has a normal physical examination today.

Click a left item, then click its matching right item

Items

A 41-year-old woman, BMI 23 kg/m², never-smoker. Her last cervical cancer screening with primary HPV testing was at age 38 and was negative.
A 58-year-old man, BMI 26 kg/m², who currently smokes 1 pack of cigarettes daily and has done so for the last 25 years. He had a normal screening colonoscopy at age 52.
A 23-year-old woman, BMI 24 kg/m², non-smoker. She is sexually active with a new male partner. Her last cervical cytology was normal at age 21.
A 66-year-old man, BMI 25 kg/m². He smoked a half-pack of cigarettes daily for 10 years but quit at age 30. He had a normal screening colonoscopy at age 64.

Matches

Show answer & explanation

Answer

The 41-year-old woman requires screening mammography; the 58-year-old man requires LDCT of the chest; the 23-year-old woman requires chlamydia and gonorrhea screening; and the 66-year-old man requires an abdominal ultrasound for AAA screening.
Each patient requires a specific preventive intervention based on current USPSTF guidelines. The 41-year-old woman needs a mammogram (recommended starting at age 40). The 58-year-old smoker meets all criteria for LDCT (age 50-80, 20+ pack-years). The 23-year-old woman needs STI screening (sexually active, age <25). The 66-year-old former smoker needs an abdominal ultrasound for AAA (men 65-75, any smoking history >100 cigarettes).

Step-by-Step Solution

1
Analyze the 41-year-old woman's profile.
Identified as due for screening mammography.
Current USPSTF guidelines recommend initiating biennial screening mammography at age 40. Her cervical cancer screening (primary HPV at age 38) is valid for 5 years.
2
Analyze the 58-year-old man's profile.
Identified as due for annual low-dose computed tomography (LDCT) of the chest.
He falls within the 50-80 age range, has a >20 pack-year smoking history, and is a current smoker, meeting all criteria for lung cancer screening. Colorectal screening is not due until age 62.
3
Analyze the 23-year-old woman's profile.
Identified as due for chlamydia and gonorrhea screening.
She is a sexually active woman younger than 25, which is a Grade B indication for STI screening. Her Pap smear (done at 21) is valid for 3 years, so she is not due for cervical cancer screening until age 24.
4
Analyze the 66-year-old man's profile.
Identified as due for a one-time abdominal duplex ultrasound.
He is a man between 65 and 75 years old who has a lifetime smoking history of at least 100 cigarettes (5 pack-years), meeting the criteria for abdominal aortic aneurysm screening.

Key Concept

Application of USPSTF preventive care guidelines tailored to age, biological sex, and specific clinical risk factors.
Question 1327Question →

Paramedics rush a 27-year-old male to the trauma center following a high-speed motorcycle collision. The patient is visibly distressed, confused, and diaphoretic. His temperature is 36.5°C (97.7°F), pulse is 132/min, blood pressure is 84/52 mm Hg, and respiratory rate is 28/min. Pulse oximetry shows 89% on room air. Physical assessment demonstrates leftward tracheal deviation, and breath sounds are absent over the right hemithorax with marked percussion dullness. Intravenous access is rapidly established and volume resuscitation is initiated. A 32-French thoracostomy tube is inserted into the right midaxillary line, yielding an immediate return of 1,600 mL of bright red blood. Over the subsequent 15 minutes, an additional 150 mL drains. The patient's blood pressure remains 82/50 mm Hg despite rapid infusion of 2 L of warmed crystalloid and 1 unit of uncrossmatched packed red blood cells. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Emergent right-sided thoracotomy

Answer

Emergent right-sided thoracotomy
The correct management for this patient is an emergent right-sided thoracotomy. In the setting of blunt or penetrating thoracic trauma, a massive hemothorax is a life-threatening emergency. The classic indications for urgent thoracotomy include an immediate return of >1,500 mL of blood upon tube thoracostomy insertion, or continuous bleeding of >200 mL/hour for 2 to 4 hours. This patient immediately drained 1,600 mL and remains hemodynamically unstable despite aggressive resuscitation with crystalloids and blood products. Immediate surgical exploration is required to identify and ligate the bleeding source, which is often an intercostal artery, internal mammary artery, or major pulmonary vessel.

Step-by-Step Solution

1
Assess the patient's hemodynamic status and physical examination findings.
The patient is in hemorrhagic shock with signs of right-sided pleural fluid (dullness, absent breath sounds) and mediastinal shift.
To identify life-threatening thoracic injuries during the primary trauma survey.
2
Evaluate the output from the tube thoracostomy.
An immediate drainage of 1,600 mL of blood is observed, with continued bleeding.
To determine if massive hemothorax criteria for surgery are met.
3
Determine the indication for surgical intervention.
The massive initial blood output (>1,500 mL) combined with persistent hemodynamic instability dictates emergent surgical exploration.
To achieve definitive hemostatic source control and prevent exsanguination.

Key Concept

Indications for urgent thoracotomy in a patient with a massive hemothorax include an immediate initial chest tube output greater than 1,500 mL or ongoing hemorrhage greater than 200 mL/hour for 2 to 4 hours, particularly in the setting of hemodynamic instability.
Question 1328Question →

An established 38-year-old female patient presents for follow-up regarding resistant hypertension. She reports experiencing profound muscle cramps and episodic weakness over the last month. Clinical assessment reveals a blood pressure of 168/102 mm Hg, which has remained uncontrolled despite strict adherence to maximum tolerated doses of lisinopril, amlodipine, and hydrochlorothiazide. A basic metabolic panel highlights a serum potassium level of 2.8 mEq/L. Suspecting primary hyperaldosteronism, the physician tapers her interfering medications, transitions her to doxazosin, and normalizes her potassium. Arrange the subsequent diagnostic investigations in the correct chronological order, proceeding from the initial diagnostic step to the definitive pre-surgical assessment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Measurement of plasma aldosterone concentration and plasma renin activity -> Confirmatory sodium suppression test -> High-resolution CT of the adrenal glands -> Adrenal venous sampling.
The correct diagnostic sequence for primary hyperaldosteronism begins with biochemical screening, followed by biochemical confirmation, then anatomical localization, and finally functional lateralization. First, the ratio of plasma aldosterone concentration to plasma renin activity (PAC/PRA) is measured as a highly sensitive screening tool. If elevated, the diagnosis is confirmed by demonstrating inappropriate autonomous aldosterone secretion during a sodium suppression test (such as an intravenous saline infusion). Once the biochemical diagnosis is secure, an adrenal protocol CT scan is performed to visualize the adrenal glands, rule out large suspected carcinomas, and map the venous anatomy. Finally, because non-functioning adrenal nodules are common and imaging alone cannot definitively prove which gland is hypersecreting, adrenal venous sampling (AVS) is performed to differentiate between a unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.

Step-by-Step Solution

1
Perform initial biochemical screening.
Measurement of the plasma aldosterone concentration to plasma renin activity (PAC/PRA) ratio.
A high PAC/PRA ratio is highly sensitive for detecting autonomous aldosterone production and serves as the standard first-line screen.
2
Execute biochemical confirmation.
Confirmatory sodium suppression test (e.g., intravenous saline infusion or oral sodium loading).
Screening tests can yield false positives; therefore, failure to suppress aldosterone levels in the face of a high sodium load confirms the diagnosis.
3
Obtain initial anatomical localization.
High-resolution computed tomography (CT) of the adrenal glands.
Imaging is required to exclude large malignant masses and to provide an anatomical roadmap of the adrenal veins for the interventional radiologist.
4
Perform functional lateralization.
Adrenal venous sampling (AVS).
Imaging cannot distinguish between a functional unilateral adenoma and a non-functioning incidentaloma with concurrent bilateral hyperplasia; AVS is required to prove lateralization before surgery.

Key Concept

The diagnostic workup for primary hyperaldosteronism follows a strict sequential algorithm: Screen (PAC/PRA) -> Confirm (Sodium suppression) -> Localize (Adrenal CT) -> Lateralize (Adrenal Venous Sampling).
Estimated Time:1m 30s
Question 1329Question →

A 72-year-old man comes to the clinic for a routine follow-up. He has a history of ischemic cardiomyopathy with a severely reduced left ventricular ejection fraction and recurrent, symptomatic ventricular tachycardia. He was started on amiodarone two years ago, which has successfully suppressed his arrhythmias. Over the past three months, the patient has developed progressive fatigue, increased sensitivity to cold, and a weight gain of 4.5 kg4.5\text{ kg} (9.9 lbs9.9\text{ lbs}). His other medications include lisinopril, metoprolol succinate, and aspirin. Vital signs show a blood pressure of 118/74 mmHg118/74\text{ mmHg} and a heart rate of 62/min62/\text{min}. Physical examination reveals delayed relaxation of the deep tendon reflexes.

Laboratory studies reveal:
Thyroid-stimulating hormone (TSH): 18.4 μU/mL18.4\text{ }\mu\text{U/mL} (Reference: 0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL})
Free T4: 0.5 ng/dL0.5\text{ ng/dL} (Reference: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Continue amiodarone and begin levothyroxine therapy

Answer

Continue amiodarone and begin levothyroxine therapy
The correct approach for amiodarone-induced hypothyroidism is to continue the amiodarone and administer exogenous levothyroxine. Amiodarone is highly efficacious for ventricular tachycardia, and its discontinuation in a patient with ischemic cardiomyopathy could result in fatal arrhythmias. Because amiodarone contains a large amount of iodine, it can induce hypothyroidism via the Wolff-Chaikoff effect (failure of the thyroid to escape the acute inhibitory effect of excess iodine on hormone synthesis). This side effect is easily and safely managed with levothyroxine supplementation.

Step-by-Step Solution

1
Analyze the patient's symptoms and laboratory results.
The patient exhibits fatigue, cold intolerance, weight gain, delayed reflexes, elevated TSH, and low free T4.
To establish the diagnosis of primary hypothyroidism.
2
Identify the underlying etiology of the hypothyroidism.
The hypothyroidism is an adverse effect of amiodarone, a medication with high iodine content that can inhibit thyroid hormone synthesis (Wolff-Chaikoff effect).
To determine if the etiology is related to the patient's pharmacological regimen.
3
Formulate a treatment plan that balances endocrine management with cardiovascular stability.
Initiate levothyroxine to treat the hypothyroidism while continuing amiodarone.
Amiodarone is effectively suppressing life-threatening ventricular tachycardia in a patient with ischemic cardiomyopathy. The endocrine side effect can be safely managed with exogenous hormone replacement without compromising arrhythmia control.

Key Concept

Patients who develop amiodarone-induced hypothyroidism should typically continue amiodarone (especially if it is controlling life-threatening arrhythmias) and be treated simultaneously with levothyroxine replacement therapy.
Estimated Time:1m 15s
Question 1330Question →

A 6262-year-old man with a 1010-year history of type 2 diabetes mellitus returns to the clinic for a routine follow-up. His current medication regimen includes maximum tolerated doses of metformin, empagliflozin, and a glucagon-like peptide-1 (GLP-1) receptor agonist. His hemoglobin A1c today is 9.5%9.5\%, and his home fasting blood glucose levels consistently range between 180180 and 220 mg/dL220\text{ mg/dL}. The physician and patient agree that initiating insulin therapy is the most appropriate next step. Arrange the following steps in the correct chronological sequence for intensifying and monitoring this patient's insulin therapy over the coming months according to standard diabetes care guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: (1) Initiate a once-daily basal insulin injection, (2) Titrate the basal insulin dose based on fasting blood glucose monitoring, (3) Assess postprandial blood glucose levels if HbA1c remains unmet, and (4) Add a single injection of rapid-acting prandial insulin before the largest meal.
The American Diabetes Association (ADA) recommends a stepwise approach to insulin intensification in type 2 diabetes. When oral agents and GLP-1 receptor agonists are insufficient, the first step is to initiate basal insulin. The basal dose is then systematically titrated based on fasting blood glucose readings until the fasting target is achieved. If the fasting target is met but the hemoglobin A1c remains above the individualized goal, this indicates that postprandial excursions are driving the persistent hyperglycemia. Therefore, the next step in treatment evaluation is to monitor postprandial blood glucose levels. Once postprandial hyperglycemia is confirmed, the treatment is further intensified by adding a dose of rapid-acting prandial insulin, usually starting with the largest or most carbohydrate-heavy meal of the day.

Step-by-Step Solution

1
Address the high fasting blood glucose.
Initiate basal insulin.
Basal insulin targets fasting hyperglycemia, which is the primary driver of HbA1c elevation in this range.
2
Evaluate and optimize the initial therapy.
Titrate basal insulin.
The initial basal dose must be adjusted upward until the fasting blood glucose reaches the therapeutic target (typically 8080 to 130 mg/dL130\text{ mg/dL}).
3
Investigate persistent overall hyperglycemia (elevated HbA1c) despite achieving fasting targets.
Measure postprandial blood glucose.
If fasting levels are normal but HbA1c is high, postprandial excursions are the likely cause and must be documented.
4
Intensify therapy to address postprandial excursions.
Add rapid-acting prandial insulin.
A single dose of prandial insulin before the largest meal directly mitigates the identified postprandial hyperglycemia, completing the stepwise approach.

Key Concept

The stepwise approach to initiating, monitoring, and intensifying insulin therapy in type 2 diabetes mellitus.
Question 1331Question →

Match each patient's clinical presentation with the most appropriate next step in diagnostic evaluation and testing sequence.

Click a left item, then click its matching right item

Items

A 62-year-old patient evaluating for stable exertional angina who has an uninterpretable baseline electrocardiogram due to a complete left bundle branch block.
A 32-year-old patient with acute pleuritic chest pain and tachypnea, a normal baseline chest radiograph, and a documented severe anaphylactic allergy to iodinated contrast media.
A 45-year-old patient with generalized pruritus, fatigue, and an isolated marked elevation of alkaline phosphatase whose right upper quadrant ultrasound shows no biliary ductal dilation.
A 24-year-old patient with acute-onset high fever, nuchal rigidity, and severe headache, who has a normal level of consciousness, no focal neurologic deficits, and no papilledema.

Matches

Show answer & explanation

Answer

The correct pairings align pre-test clinical constraints with established diagnostic algorithms: complete LBBB requires pharmacologic stress imaging; iodinated contrast allergy with a normal chest radiograph requires V/Q scanning; intrahepatic cholestasis without ductal dilation requires anti-mitochondrial antibody testing; and classic meningitis symptoms without high-risk neurologic features require immediate lumbar puncture without a prior CT scan.
Each pairing represents the most efficient, cost-effective, and safe diagnostic step for the specific clinical constraints presented. The matching relies on bypassing conventional first-line tests when contraindications exist (e.g., LBBB preventing standard exercise ECG, contrast allergy preventing CTPA) or following standard algorithmic progression (e.g., a negative ultrasound leading to serologic testing for primary biliary cholangitis; the absence of high-risk neurological features allowing direct lumbar puncture).

Step-by-Step Solution

1
Analyze the baseline diagnostic constraints and prior test results for each patient scenario.
Identified key limiting factors: complete LBBB, anaphylaxis to contrast, lack of biliary dilation on ultrasound, and absence of 'red flag' neurological signs.
Accurate test sequencing heavily depends on recognizing absolute contraindications or prerequisites for standard first-line investigations.
2
Determine the appropriate guideline-directed alternative or subsequent diagnostic test based on the identified constraints.
Selected pharmacologic stress testing, V/Q scan, AMA titers, and direct lumbar puncture respectively.
Bypassing contraindicated initial tests or proceeding efficiently with the next algorithmic step prevents misdiagnosis, avoids unnecessary healthcare costs, and prevents treatment delays.

Key Concept

Clinical algorithms for diagnostic test sequencing frequently require modification based on baseline patient characteristics, absolute contraindications to specific modalities, and the presence or absence of exclusionary criteria.
Question 1332Question →

Match the following clinical presentations evaluated in the emergency department to the most appropriate initial disposition care setting.

Click a left item, then click its matching right item

Items

A 58-year-old man with refractory angina, positive cardiac biomarkers, and dynamic ischemic electrocardiogram changes despite maximum intravenous medical therapy.
A 71-year-old woman with a chronic obstructive pulmonary disease exacerbation who is stabilizing on continuous positive airway pressure (CPAP) but requires frequent respiratory assessments.
A 65-year-old man with acute decompensated heart failure who is hemodynamically stable but requires ongoing intravenous diuresis and continuous cardiac telemetry.
A 48-year-old woman presenting with atypical chest pain and normal serial electrocardiograms and troponins, who requires provocative stress testing before definitive clearance.
A 35-year-old man with pleuritic chest pain diagnosed as viral pleurisy, with normal vital signs, a normal electrocardiogram, and well-controlled pain on oral nonsteroidal anti-inflammatory drugs.

Matches

Show answer & explanation

Answer

The correct dispositions map high-risk ischemia to the Intensive Care Unit, non-invasive ventilation requirements to a Step-down Unit, stable intravenous diuresis to the General Medical Ward, brief risk stratification to an Observation Unit, and stable, non-life-threatening conditions to Home Discharge.
Appropriate disposition ensures patient safety while optimizing healthcare resource utilization. Patients with refractory ischemia require intensive care for potential rapid deterioration and advanced interventions. Patients on continuous non-invasive ventilation require intermediate (step-down) care for close respiratory monitoring and frequent nursing assessments. Hemodynamically stable patients on routine intravenous therapies are appropriate for general medical wards. Observation units are specifically designed for short-term, protocol-driven risk stratification (e.g., ruling out acute coronary syndrome), while stable, low-risk patients can safely follow up in the outpatient setting.

Step-by-Step Solution

1
Evaluate hemodynamic stability, oxygenation status, and the need for life-sustaining interventions for each patient.
Identifies patients requiring high-acuity interventions (Intensive Care or Step-down units).
Determines the maximum level of nursing care, continuous monitoring, and physician presence required to prevent adverse events.
2
Assess the need for ongoing inpatient therapeutic management versus diagnostic risk stratification.
Separates patients needing full inpatient admission (e.g., intravenous diuresis) from those needing brief monitoring and testing (Observation Unit).
Prevents unnecessary utilization of full inpatient beds and prolonged hospital stays for patients only requiring short-term evaluation.
3
Identify patients meeting criteria for safe outpatient management.
Determines which patients can be discharged home immediately.
Ensures safe transitions of care while avoiding unnecessary hospitalizations, minimizing healthcare costs, and reducing nosocomial risks.

Key Concept

Triage and disposition decisions rely on matching a patient's physiologic stability, nursing care intensity requirements, and need for acute interventions with the capabilities of the receiving care setting.
Question 1333Question →

A 78-year-old man is evaluated in the intensive care unit for a new-onset fever. He was admitted 4 days ago for severe community-acquired pneumonia and currently requires mechanical ventilation and continuous norepinephrine infusion to maintain adequate perfusion. His past medical history is significant for severe chronic obstructive pulmonary disease and ischemic cardiomyopathy with an ejection fraction of 25%25\%. Temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 90/60 mmHg90/60\text{ mmHg} (on vasopressors), pulse is 115/min115/\text{min}, and respirations are fully supported by the ventilator. Physical examination reveals a sedated patient who grimaces and guards when deep palpation is applied to the right upper quadrant. Laboratory studies show a leukocyte count of 22,000/μL22,000/\mu\text{L}, total bilirubin of 1.8 mg/dL1.8\text{ mg/dL}, and alkaline phosphatase of 210 U/L210\text{ U/L}. Aminotransferase levels are within normal limits. A right upper quadrant ultrasound demonstrates a markedly distended gallbladder with a wall thickness of 6 mm6\text{ mm}, pericholecystic fluid, and biliary sludge, but no gallstones are visualized. Which of the following is the most appropriate next step in the management of this patient's abdominal condition?

Show answer & explanation

Answer: Placement of a percutaneous cholecystostomy tube

Answer

Placement of a percutaneous cholecystostomy tube is the correct management step.
This patient has developed acute acalculous cholecystitis, a highly morbid condition typically seen in critically ill, hospitalized patients (e.g., those requiring mechanical ventilation, vasopressors, or total parenteral nutrition). The lack of enteral feeding leads to biliary stasis, ischemia, and subsequent inflammation. Prompt source control is necessary to prevent gallbladder necrosis, gangrene, and perforation. While cholecystectomy is the definitive treatment, this patient is hemodynamically unstable, dependent on a ventilator, and has severe underlying cardiac disease, making him an extremely poor surgical candidate. In such high-risk patients, percutaneous cholecystostomy tube placement is the preferred procedural intervention. It effectively decompresses the infected gallbladder and provides source control under local anesthesia, bridging the patient to definitive surgery once they recover or serving as a definitive treatment if they remain unfit for surgery.

Step-by-Step Solution

1
Diagnose the acute condition based on clinical and ultrasound findings.
The patient has acute acalculous cholecystitis, characterized by fever, leukocytosis, right upper quadrant tenderness, and ultrasound findings of gallbladder wall thickening and pericholecystic fluid without gallstones in the setting of critical illness.
Establishing the correct diagnosis guides the urgency and type of intervention.
2
Evaluate the patient's surgical risk and hemodynamic stability.
The patient is on vasopressors, requires mechanical ventilation, and has a severe ischemic cardiomyopathy (EF 25%25\%), making him a prohibitively high-risk candidate for surgical intervention under general anesthesia.
Surgical risk stratification determines whether definitive treatment (cholecystectomy) or a temporizing, minimally invasive measure is required.
3
Select the safest procedural intervention for source control.
Percutaneous cholecystostomy tube placement provides necessary gallbladder decompression and source control without the hemodynamic stress of surgery.
Critically ill patients with acalculous cholecystitis require drainage to prevent gallbladder necrosis and perforation.

Key Concept

In critically ill patients who develop acute acalculous cholecystitis and are poor surgical candidates, placement of a percutaneous cholecystostomy tube is the most appropriate procedural intervention for source control.
Question 1334Question →

Emergency medical services bring a 55-year-old woman to the emergency department due to a severe, sudden-onset headache. The patient reports that the pain struck her abruptly 12 hours prior to arrival, describing it as feeling like she was "hit by a lightning bolt." She notes accompanying photophobia and nausea but denies any preceding trauma or fever. Her past medical history includes hypertension managed with amlodipine. Upon arrival, her blood pressure is 168/95 mmHg, pulse is 94/min, and temperature is 37.1°C (98.8°F). Physical examination shows a distressed patient clutching her head. A neurologic assessment reveals mild nuchal rigidity but intact cranial nerves and no focal motor or sensory deficits. A non-contrast computed tomography (CT) scan of the brain is obtained and demonstrates no intracranial hemorrhage, mass effect, or midline shift. Which of the following is the most appropriate next step in diagnostic evaluation?

Show answer & explanation

Answer: Lumbar puncture

Answer

The correct answer is to perform a lumbar puncture.
The correct sequence of diagnostic testing for a suspected subarachnoid hemorrhage begins with a non-contrast head CT. While highly sensitive within the first 6 hours of symptom onset, the sensitivity of a CT scan drops significantly thereafter. Because this patient's symptoms began 12 hours ago, the negative CT scan does not definitively rule out a subarachnoid hemorrhage. Therefore, the mandatory next step in the diagnostic sequence is a lumbar puncture to analyze the cerebrospinal fluid for red blood cells and xanthochromia (bilirubin resulting from hemoglobin breakdown).

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient has a sudden-onset "thunderclap" headache with nuchal rigidity, which is highly suspicious for a subarachnoid hemorrhage (SAH).
Recognizing the hallmark symptoms of life-threatening conditions is the first step in determining the correct diagnostic pathway.
2
Evaluate the results of the initial diagnostic testing in the context of the timeline.
The initial non-contrast head CT is negative; however, it was performed 12 hours after symptom onset, at which point CT sensitivity for acute SAH is significantly reduced.
Understanding the temporal limitations of imaging modalities is critical for deciding if further testing is required to rule out a diagnosis.
3
Determine the appropriate guideline-directed next step in the diagnostic sequence.
Cerebrospinal fluid analysis must be performed to check for red blood cells and xanthochromia.
When a high-risk diagnosis cannot be confidently excluded by initial screening due to temporal factors, the definitive sequential test must be utilized.

Key Concept

In patients with a high clinical suspicion for subarachnoid hemorrhage and a negative non-contrast head CT (especially greater than 6 hours from symptom onset), a lumbar puncture is required as the sequential next step to definitively evaluate for the presence of blood or xanthochromia.
Question 1335Question →

Match each patient presentation in the primary care setting with the single most appropriate, guideline-concordant preventive care intervention.

Click a left item, then click its matching right item

Items

31-year-old patient presenting for a routine evaluation who has never been previously tested for HIV
29-year-old pregnant patient at 28 weeks gestation, up to date on all childhood vaccines
46-year-old asymptomatic patient with no family history of gastrointestinal malignancy
41-year-old patient with no significant past medical history who has never been tested for hepatitis C

Matches

Show answer & explanation

Answer

Each patient profile correctly maps to its specific, guideline-indicated preventive screening or immunization according to current USPSTF and ACIP age and risk criteria.
The correct pairings directly apply the most current, evidence-based recommendations from the USPSTF and ACIP. The 31-year-old requires one-time HIV screening; the pregnant patient requires a Tdap vaccine in the third trimester; the 46-year-old requires the initiation of colorectal cancer screening; and the 41-year-old requires one-time HCV screening.

Step-by-Step Solution

1
Analyze the 31-year-old patient's preventive care needs.
Identified requirement for HIV screening.
All adults aged 15 to 65 years require at least one-time HIV screening.
2
Evaluate the 29-year-old pregnant patient's gestational age and vaccination needs.
Identified indication for Tdap administration.
Tdap must be given during every pregnancy at 27-36 weeks to maximize passive antibody transfer to the infant.
3
Assess the 46-year-old asymptomatic patient's age-related cancer screening requirements.
Identified indication for colorectal cancer screening.
Recent guideline updates lowered the starting age for average-risk colorectal cancer screening from 50 to 45 years.
4
Determine the infectious disease screening needs for the 41-year-old patient.
Identified requirement for HCV antibody screening.
Universal one-time HCV screening is indicated for all adults aged 18 to 79 years, regardless of specific risk factors.

Key Concept

Preventive Care and Screening Guidelines
Estimated Time:1m 0s
Question 1336Question →

A 62-year-old woman is brought to the emergency department by her family due to a 2-day history of progressively worsening severe right-sided abdominal pain, high fever, and new-onset confusion. Her past medical history is significant for hypertension and hyperlipidemia. On arrival, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 84/52 mm Hg84/52\text{ mm Hg}, heart rate is 122/min122/\text{min}, and respiratory rate is 24/min24/\text{min}. Physical examination reveals marked scleral icterus, dry mucous membranes, and significant tenderness to palpation in the right upper quadrant without rebound or guarding. The patient is lethargic and disoriented to time and place. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3, a total bilirubin of 6.2 mg/dL6.2\text{ mg/dL}, direct bilirubin of 4.8 mg/dL4.8\text{ mg/dL}, and an alkaline phosphatase of 450 U/L450\text{ U/L}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initial stabilization with IV fluids and antibiotics, followed by a right upper quadrant ultrasound, then urgent ERCP, and finally an elective laparoscopic cholecystectomy.
The patient presents with classic signs of Reynolds pentad (fever, jaundice, right upper quadrant pain, hypotension, and altered mental status), indicating severe acute ascending cholangitis complicated by septic shock. The standard sequence of management for such a surgical emergency begins with immediate patient stabilization, which includes aggressive intravenous fluid resuscitation and broad-spectrum antibiotics to address the septic shock. Once stabilizing measures are initiated, a right upper quadrant ultrasound must be obtained to confirm the diagnosis by visualizing common bile duct dilation and potential choledocholithiasis. Following diagnostic confirmation, urgent biliary decompression is required because medical management alone is inadequate for severe suppurative cholangitis; ERCP is the procedure of choice. Finally, after the patient is stabilized and recovers from the acute illness, an elective laparoscopic cholecystectomy should be performed prior to hospital discharge to prevent recurrent biliary events.

Step-by-Step Solution

1
Recognize the clinical presentation of severe acute cholangitis.
The patient exhibits Reynolds pentad (fever, right upper quadrant pain, jaundice, hypotension, altered mental status).
Identifying the severity of the condition dictates the urgency of intervention.
2
Prioritize initial hemodynamic stabilization.
Administer isotonic crystalloids and broad-spectrum intravenous antibiotics.
The patient is in septic shock; delaying resuscitation can lead to multiorgan failure and death.
3
Confirm the diagnosis with noninvasive imaging.
Obtain a right upper quadrant abdominal ultrasound.
Ultrasound quickly and safely confirms common bile duct dilation and helps rule out other acute abdominal pathologies.
4
Decompress the biliary tree urgently.
Perform urgent endoscopic retrograde cholangiopancreatography (ERCP).
In severe (suppurative) cholangitis, medical management alone is insufficient, and urgent purulent drainage via ERCP is required.
5
Plan definitive surgical management.
Perform a laparoscopic cholecystectomy.
After the acute episode resolves, removing the source of the gallstones prevents future life-threatening occurrences.

Key Concept

The management of severe acute ascending cholangitis requires sequential steps: immediate hemodynamic stabilization, noninvasive diagnostic confirmation, urgent biliary decompression, and subsequent definitive surgical care.
Question 1337Question →

A 42-year-old woman presents to the outpatient clinic for evaluation of a neck lump she noticed two weeks ago while applying lotion. She denies dysphagia, dysphonia, weight changes, palpitations, tremors, or cold intolerance. Her medical history is unremarkable, and she takes no medications. She has no personal or family history of head or neck radiation or thyroid cancer. Vital signs include a blood pressure of 118/76 mmHg, pulse of 72/min, and temperature of 37.0°C (98.6°F). Physical examination reveals a palpable, 2.5-cm, firm, mobile, non-tender nodule in the right lobe of the thyroid gland. The remainder of the thyroid gland is not enlarged, and there is no cervical lymphadenopathy. Which of the following tests should be ordered as the INITIAL steps in evaluating this patient's nodule? (Select the two most appropriate tests)

Select all that apply

Show answer & explanation

Answer: Measurement of serum thyroid-stimulating hormone; Thyroid ultrasonography

Answer

The correct initial steps are the measurement of serum thyroid-stimulating hormone (TSH) and thyroid ultrasonography.
The initial evaluation of any newly discovered thyroid nodule requires two concurrent steps: evaluating the functional status of the thyroid gland and assessing the anatomical characteristics of the nodule. Measurement of serum thyroid-stimulating hormone (TSH) is the most sensitive test for determining thyroid function. Thyroid ultrasonography is the imaging modality of choice to confirm the presence of a nodule, measure its exact dimensions, evaluate for suspicious sonographic features (e.g., solid composition, hypoechogenicity, irregular margins, microcalcifications), and check for abnormal cervical lymph nodes. Together, these two tests dictate the subsequent algorithm, specifically determining whether the patient requires a radionuclide scan or an ultrasound-guided fine-needle aspiration biopsy.

Step-by-Step Solution

1
Identify the primary clinical problem
The patient presents with an asymptomatic, palpable thyroid nodule with no clinical signs of hyperthyroidism or hypothyroidism.
Establishing the clinical baseline directs whether emergency stabilization or routine diagnostic workup is required.
2
Determine the first-line biochemical evaluation
Select serum TSH measurement.
TSH determines the functional status of the nodule. A low TSH indicates a hyperfunctioning nodule (requiring a radionuclide scan), whereas a normal or high TSH requires risk stratification for malignancy.
3
Determine the first-line anatomical evaluation
Select thyroid ultrasonography.
Ultrasound provides the necessary anatomical details (size, composition, margins, echogenicity, microcalcifications) to stratify the risk of malignancy and determine if a biopsy is indicated.

Key Concept

The initial concurrent workup of a newly discovered thyroid nodule consists of both a biochemical assessment (serum TSH) and an anatomical assessment (thyroid ultrasonography).
Question 1338Question →

During a routine cardiovascular follow-up, a 65-year-old male patient is evaluated for long-term care planning. He was diagnosed with nonvalvular atrial fibrillation three weeks ago and subsequently initiated on apixaban for thromboembolic prevention. His medical history includes hypertension and stage 2 chronic kidney disease. His daily regimen consists of apixaban, lisinopril, and amlodipine. He denies any recent bleeding, unusual bruising, or palpitations. As part of guideline-directed medical therapy, which TWO of the following parameters must be included in his routine, long-term surveillance plan? (Select two)

Select all that apply

Show answer & explanation

Answer: Assessment of serum creatinine and estimated glomerular filtration rate at least annually; Assessment of hemoglobin and hematocrit at least annually

Answer

The necessary monitoring parameters are the assessment of serum creatinine and estimated glomerular filtration rate at least annually, and the assessment of hemoglobin and hematocrit at least annually.
Direct oral anticoagulants (DOACs) such as apixaban offer the advantage of predictable pharmacokinetics, thereby eliminating the need for routine monitoring of coagulation times. However, safe long-term use requires specific surveillance. First, because DOACs are partially eliminated via the kidneys, a decline in renal function can lead to drug accumulation and major bleeding; therefore, serum creatinine and estimated glomerular filtration rate (eGFR) must be evaluated at least annually (and more frequently in those with advanced age or established chronic kidney disease). Second, because these agents inherently disrupt hemostasis, patients are at risk for chronic, asymptomatic blood loss (particularly from the gastrointestinal tract). As a result, an annual complete blood count or assessment of hemoglobin and hematocrit is essential to detect occult bleeding early.

Step-by-Step Solution

1
Identify the primary medication being evaluated and its drug class.
The patient is taking apixaban, which is a direct oral anticoagulant (DOAC) specifically targeting factor Xa.
Different classes of anticoagulants have distinct monitoring requirements and safety profiles.
2
Determine the clearance mechanisms and primary adverse effects associated with this medication class.
Apixaban is partially cleared by the kidneys, and like all anticoagulants, its primary adverse effect is bleeding.
Understanding pharmacokinetics and side effect profiles dictates what organ systems need routine surveillance.
3
Apply guideline-directed surveillance protocols for long-term DOAC therapy.
Guidelines mandate at least annual monitoring of renal function to ensure appropriate dosing, and annual hemoglobin/hematocrit monitoring to detect occult bleeding.
This ensures both continued efficacy (proper dosing) and patient safety over the course of lifelong therapy.

Key Concept

Patients receiving direct oral anticoagulants (DOACs) require at least annual monitoring of renal function to guide dosing adjustments and annual complete blood counts to screen for occult hemorrhage, but do not require routine coagulation testing.
Question 1339Question →

A 78-year-old woman with a history of congestive heart failure and chronic kidney disease is hospitalized for a severe heart failure exacerbation. After a 5-day stay, she has reached clinical stability. The interdisciplinary team is preparing her for transition to a skilled nursing facility (SNF) for subacute rehabilitation. To ensure patient safety, prevent medication errors, and minimize readmission risk, arrange the following steps of the transitions-of-care pathway in the correct chronological sequence according to standard safe discharge practices.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The chronological sequence is: 1) Needs assessment to determine disposition, 2) Medication reconciliation to finalize the regimen, 3) Patient/caregiver education via teach-back, 4) Transmission of the discharge summary to receiving clinicians, and 5) Post-transition telephone outreach.
A safe and effective transition of care pathway follows a logical chronological progression designed to eliminate gaps in patient safety. Early assessment of functional and social needs determines the appropriate disposition setting (e.g., SNF) well before the actual discharge date. As the patient approaches clinical stability, a rigorous medication reconciliation must be performed to finalize the discharge regimen and prevent polypharmacy or omissions. Only after this regimen is finalized can meaningful, teach-back education be provided to the patient and family. At the time of physical transfer, a comprehensive discharge summary must be communicated to the receiving clinicians to ensure immediate continuity of care. Finally, a post-transition outreach call is conducted within 48-72 hours to ensure the plan is being executed safely and to intercept early signs of clinical deterioration.

Step-by-Step Solution

1
Assess functional status and post-discharge needs.
Determination of the safest disposition setting (SNF).
Disposition planning must begin early in the hospital course to allow adequate time for facility coordination and insurance approval.
2
Complete discharge medication reconciliation.
Generation of an accurate, finalized list of post-discharge medications.
Resolving discrepancies between home medications and hospital therapies prevents adverse drug events and is required before counseling the patient.
3
Provide teach-back education to the patient and family.
Confirmation of patient understanding regarding medications and warning signs.
Patients must understand their finalized care plan before leaving the hospital to prevent early readmissions.
4
Transmit the discharge summary and records to the SNF.
Seamless transfer of medical information to the accepting clinicians.
Receiving providers require immediate access to the reconciled medication list and hospital course summary to safely assume care upon the patient's arrival.
5
Execute post-transition telephone outreach.
Verification of clinical stability and adherence in the new setting.
A systematic follow-up within 48-72 hours identifies gaps in care, such as missing medications or early symptom recurrence, mitigating the risk of readmission.

Key Concept

Safe transitions of care follow a structured pathway: early disposition assessment, formalized medication reconciliation, teach-back patient education, standardized clinician-to-clinician handoff, and early post-discharge follow-up.
Estimated Time:1m 30s
Question 1340Question →

A 48-year-old woman comes to the clinic for evaluation of progressive weight gain, fatigue, and easy bruising over the past 8 months. She reports difficulty climbing stairs due to proximal leg weakness. Her medical history is unremarkable, and she takes no medications. Her blood pressure is 162/98 mm Hg, and her pulse is 82/min. Physical examination reveals a plethoric face, prominent supraclavicular fat pads, and broad, violaceous striae over the lower abdomen. Which of the following is the most appropriate next step in the diagnostic evaluation of this patient?

Show answer & explanation

Answer: Measurement of late-night salivary cortisol concentration

Answer

Measurement of late-night salivary cortisol concentration
The correct answer is the measurement of late-night salivary cortisol concentration. This patient presents with classic clinical features of Cushing syndrome. The diagnostic workup for Cushing syndrome must follow a strict sequence to avoid false-positive localizations. The first mandatory step is to biochemically establish the presence of pathological hypercortisolism. This is achieved by utilizing one of three first-line screening tests: late-night salivary cortisol (assessing the loss of normal diurnal variation), 24-hour urine free cortisol (assessing total daily production), or a low-dose (1-mg) overnight dexamethasone suppression test (assessing the loss of normal negative feedback).

Step-by-Step Solution

1
Identify the clinical syndrome presented by the patient.
The patient exhibits classic signs of Cushing syndrome, including progressive weight gain, proximal muscle weakness, easy bruising, facial plethora, supraclavicular fat pads, broad violaceous striae, and secondary hypertension.
Recognizing the constellation of symptoms dictates the specific diagnostic pathway for hypercortisolism.
2
Determine the first step in the established diagnostic sequence for the suspected condition.
The initial step in evaluating suspected Cushing syndrome is confirming the presence of endogenous hypercortisolism using one of three recommended screening tests.
Biochemical confirmation of the disease state must precede any attempts to localize the source of the hormone excess.
3
Select the appropriate screening test from the available options.
Late-night salivary cortisol is one of the validated initial screening tests. The other options represent tests utilized further down the diagnostic algorithm or inappropriate tests.
Diagnostic test sequencing strictly requires establishing hypercortisolism before measuring ACTH or performing imaging.

Key Concept

The initial evaluation of suspected Cushing syndrome requires confirming hypercortisolism with a 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test before assessing ACTH levels or performing imaging.
Estimated Time:1m 15s
PreviousPage 67 / 104Next